
Adaptimmune Therapeutics plc ADAP
Quarterly report 2025-Q2
added 08-13-2025
Adaptimmune Therapeutics plc P/S Ratio 2011-2025 | ADAP
Annual P/S Ratio Adaptimmune Therapeutics plc
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 34 | 46.3 | 444 | 1.18 K | 2.25 M | 45.8 K | 121 K | 125 K | 737 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.25 M | 34 | 282 K |
P/S Ratio of other stocks in the Biotechnology industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M | ||
|
Arbutus Biopharma Corporation
ABUS
|
24.5 | $ 4.77 | -0.42 % | $ 792 M | ||
|
Aclaris Therapeutics
ACRS
|
8.13 | $ 3.03 | -0.33 % | $ 234 M | ||
|
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | ||
|
Alpine Immune Sciences
ALPN
|
8.94 | - | - | $ 2.17 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | ||
|
Aptorum Group Limited
APM
|
105 | $ 1.17 | - | $ 6.38 M | ||
|
Ampio Pharmaceuticals
AMPE
|
106 | - | -11.43 % | $ 502 K | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
137 | - | -18.52 % | $ 27.3 M | ||
|
Ascendis Pharma A/S
ASND
|
947 | $ 208.91 | -1.83 % | $ 5 B | ||
|
Aptevo Therapeutics
APVO
|
3.11 | $ 0.58 | -37.75 % | $ 160 K | ||
|
Alterity Therapeutics Limited
ATHE
|
131 | $ 3.11 | 0.49 % | $ 7.48 B | ||
|
Athersys
ATHX
|
253 | - | 3.77 % | $ 22.4 M | ||
|
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - | ||
|
Acasti Pharma
ACST
|
0.203 | - | 4.01 % | $ 150 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
759 | $ 0.22 | 26.23 % | $ 479 M | ||
|
BioDelivery Sciences International
BDSI
|
1.85 | - | -4.8 % | $ 255 M | ||
|
Albireo Pharma
ALBO
|
13.3 | - | -0.23 % | $ 916 M | ||
|
BioNTech SE
BNTX
|
35.7 | $ 94.4 | -0.67 % | $ 27.2 B | ||
|
Amphastar Pharmaceuticals
AMPH
|
1.79 | $ 26.93 | 0.45 % | $ 1.3 B | ||
|
BeiGene, Ltd.
BGNE
|
66.4 | - | 0.49 % | $ 251 B | ||
|
Anika Therapeutics
ANIK
|
2.24 | $ 9.56 | 0.8 % | $ 140 M | ||
|
Bellicum Pharmaceuticals
BLCM
|
5.55 | - | -9.72 % | $ 5.89 M | ||
|
Berkeley Lights
BLI
|
1.49 | - | -7.31 % | $ 87 M | ||
|
bluebird bio
BLUE
|
2.27 | - | - | $ 546 M | ||
|
Arena Pharmaceuticals
ARNA
|
105 K | - | -6.81 % | $ 3.04 B | ||
|
Acer Therapeutics
ACER
|
25.8 | - | 2.71 % | $ 14 M | ||
|
Calithera Biosciences
CALA
|
98.5 | - | -10.95 % | $ 876 K | ||
|
Axon Enterprise
AXON
|
19.1 | $ 585.17 | -1.01 % | $ 44.3 B | ||
|
Ayala Pharmaceuticals
AYLA
|
11.2 | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
0.237 | $ 2.46 | -2.72 % | $ 15.4 M | ||
|
AstraZeneca PLC
AZN
|
2.17 | $ 92.63 | 0.19 % | $ 96.9 B | ||
|
Acorda Therapeutics
ACOR
|
0.142 | - | -24.86 % | $ 820 K | ||
|
Catalyst Biosciences
CBIO
|
0.296 | $ 12.41 | 0.32 % | $ 817 M | ||
|
Brickell Biotech
BBI
|
1.42 | - | -5.38 % | $ 6.06 M | ||
|
Celldex Therapeutics
CLDX
|
0.187 | $ 26.37 | -1.73 % | $ 1.7 M | ||
|
Burford Capital Limited
BUR
|
6.35 | $ 9.05 | 0.56 % | $ 1.48 B | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
18.6 | $ 10.85 | 0.37 % | $ 702 M | ||
|
Biogen
BIIB
|
2 | $ 176.17 | -0.09 % | $ 25.7 B |